Model-Informed Precision Dosing at the Bedside: Scientific Challenges and Opportunities
- PMID: 30255663
- PMCID: PMC6310898
- DOI: 10.1002/psp4.12353
Model-Informed Precision Dosing at the Bedside: Scientific Challenges and Opportunities
Abstract
The development of model-informed precision dosing (MIPD) tools, especially in the form of native or web-based applications to be used at the bedside, has garnered marked attention in recent years. Their potential clinical benefit can be large, but it should be ensured that such tools make optimal use of available clinical data and have adequate predictive ability. Unique scientific challenges specific to MIPD remain, which may require adaptation of commonly used diagnostics in pharmacometrics.
© 2018 The Authors CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics.
Figures
References
-
- Sheiner, L.B. Computer‐aided long‐term anticoagulation therapy. Comput. Biomed. Res. 2, 507–518 (1969). - PubMed
-
- Darwich, A.S. et al Why has model‐informed precision dosing not yet become common clinical reality? Lessons from the past and a roadmap for the future. Clin. Pharmacol. Ther. 101, 646–656 (2017). - PubMed
-
- Chan, D. , Ivaturi, V. & Long‐Boyle, J. The time is now: model‐based dosing to optimize drug therapy. Int. J. Pharmacokinet. 2, 213–215 (2017).
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
